How-Sung Lee

983 total citations
17 papers, 823 citations indexed

About

How-Sung Lee is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, How-Sung Lee has authored 17 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pharmacology and 4 papers in Molecular Biology. Recurrent topics in How-Sung Lee's work include Pharmacogenetics and Drug Metabolism (5 papers), Drug Transport and Resistance Mechanisms (3 papers) and Cancer Treatment and Pharmacology (3 papers). How-Sung Lee is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Drug Transport and Resistance Mechanisms (3 papers) and Cancer Treatment and Pharmacology (3 papers). How-Sung Lee collaborates with scholars based in Singapore, United States and New Zealand. How-Sung Lee's co-authors include Boon-Cher Goh, Lu Fan, Lingzhi Wang, Soo Chin Lee, Sudhir H. Ranganath, Chi‐Hwa Wang, Robert C. Lim, Ai-Bee Ong, Jiayi Guo and Jatinder K. Lamba and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biomaterials.

In The Last Decade

How-Sung Lee

17 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
How-Sung Lee Singapore	12	324	217	175	154	121	17	823
Philip Chaikin United States	17	154 0.5×	284 1.3×	97 0.6×	129 0.8×	94 0.8×	32	1.3k
Claude Dagenais Canada	10	727 2.2×	545 2.5×	88 0.5×	136 0.9×	65 0.5×	11	1.5k
M.G. Donelli Italy	19	474 1.5×	305 1.4×	157 0.9×	50 0.3×	45 0.4×	60	1.1k
Julie Marill France	12	149 0.5×	476 2.2×	142 0.8×	84 0.5×	202 1.7×	14	931
Ornella Fantappiè Italy	19	322 1.0×	484 2.2×	33 0.2×	45 0.3×	50 0.4×	28	1.2k
Takafumi Komori Japan	11	700 2.2×	206 0.9×	188 1.1×	40 0.3×	35 0.3×	19	893
Frederike K. Engels Netherlands	13	294 0.9×	138 0.6×	82 0.5×	131 0.9×	59 0.5×	17	681
Sandra Strychor United States	18	328 1.0×	359 1.7×	36 0.2×	235 1.5×	124 1.0×	41	833
J. William Higgins United States	14	448 1.4×	728 3.4×	167 1.0×	29 0.2×	304 2.5×	20	1.5k
Candace Graff United States	10	343 1.1×	201 0.9×	68 0.4×	57 0.4×	30 0.2×	15	983

Countries citing papers authored by How-Sung Lee

Since Specialization

Citations

This map shows the geographic impact of How-Sung Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by How-Sung Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites How-Sung Lee more than expected).

Fields of papers citing papers by How-Sung Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by How-Sung Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by How-Sung Lee. The network helps show where How-Sung Lee may publish in the future.

Co-authorship network of co-authors of How-Sung Lee

This figure shows the co-authorship network connecting the top 25 collaborators of How-Sung Lee. A scholar is included among the top collaborators of How-Sung Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with How-Sung Lee. How-Sung Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Wang, Lingzhi, Winnie Yeo, Jieying Amelia Lau, et al.. (2014). Correction: Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients. PLoS ONE. 9(1). 1 indexed citations

Hua, Fei, Lih‐Wen Deng, Yok Moi Khoo, et al.. (2011). Regulation of Heart Function by Endogenous Gaseous Mediators—Crosstalk Between Nitric Oxide and Hydrogen Sulfide. Antioxidants and Redox Signaling. 14(11). 2081–2091. 71 indexed citations

Ranganath, Sudhir H., Davis Yohanes Arifin, Irene Kee, et al.. (2010). The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice. Biomaterials. 31(19). 5199–5207. 98 indexed citations

Ranganath, Sudhir H., Lai Yeng Lee, Lu Fan, et al.. (2009). Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme. Biomaterials. 30(18). 3189–3196. 116 indexed citations

Wang, Lingzhi, Ross A. Soo, How-Sung Lee, et al.. (2008). Does saturable formation of gemcitabine triphosphate occur in patients?. Cancer Chemotherapy and Pharmacology. 63(1). 55–64. 16 indexed citations

Fan, Lu, Boon-Cher Goh, Sing‐Huang Tan, et al.. (2008). Genotype of human carbonyl reductase CBR3 correlates with doxorubicin disposition and toxicity. Pharmacogenetics and Genomics. 18(7). 623–631. 74 indexed citations

Wang, Lingzhi, Ross A. Soo, Soo Chin Lee, et al.. (2008). A Pharmacodynamic Model for the Time Course of Tumor Shrinkage by Gemcitabine + Carboplatin in Non–Small Cell Lung Cancer Patients. Clinical Cancer Research. 14(13). 4213–4218. 52 indexed citations

Yong, Wei Peng, et al.. (2007). A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers. Cancer Chemotherapy and Pharmacology. 62(2). 243–251. 10 indexed citations

Holford, Nicholas H. G., et al.. (2007). Lack of Association of Single-Nucleotide Polymorphisms in Pregnane X Receptor, Hepatic Nuclear Factor 4α, and Constitutive Androstane Receptor with Docetaxel Pharmacokinetics. Clinical Cancer Research. 13(23). 7126–7132. 18 indexed citations

10.

Wang, Qing, Xian Nan Tang, Lingzhi Wang, et al.. (2006). Effects of high dose of simvastatin on levels of dopamine and its reuptake in prefrontal cortex and striatum among SD rats. Neuroscience Letters. 408(3). 189–193. 24 indexed citations

11.

Lee, How-Sung, Lingzhi Wang, Wei Peng Yong, et al.. (2006). Ketoconazole Renders Poor CYP3A Phenotype Status With Midazolam as Probe Drug. Therapeutic Drug Monitoring. 28(2). 255–261. 10 indexed citations

12.

Wang, Lingzhi, Boon-Cher Goh, How-Sung Lee, Paul Noordhuis, & Godefridus J. Peters. (2003). An Expedient Assay for Determination of Gemcitabine and Its Metabolite in Human Plasma Using Isocratic Ion-Pair Reversed-Phase High-Performance Liquid Chromatography. Therapeutic Drug Monitoring. 25(5). 552–557. 19 indexed citations

13.

Lü, Wan-Liang, Qiang Zhang, How-Sung Lee, et al.. (2003). Total Coenzyme Q10 Concentrations in Asian Men Following Multiple Oral 50-mg Doses Administered as Coenzyme Q10 Sustained Release Tablets or Regular Tablets.. Biological and Pharmaceutical Bulletin. 26(1). 52–55. 16 indexed citations

14.

Goh, Boon-Cher, Soo Chin Lee, Lingzhi Wang, et al.. (2002). Explaining Interindividual Variability of Docetaxel Pharmacokinetics and Pharmacodynamics in Asians Through Phenotyping and Genotyping Strategies. Journal of Clinical Oncology. 20(17). 3683–3690. 232 indexed citations

15.

Chong, Siow‐Ann, et al.. (1997). Clinical Evaluation and Plasma Clozapine Concentrations in Chinese Patients With Schizophrenia. Therapeutic Drug Monitoring. 19(2). 219–223. 53 indexed citations

16.

Lee, How-Sung, et al.. (1995). Pharmacokinetics of Propofol Infusion in Asian Patients Undergoing Coronary Artery Bypass Grafting. Therapeutic Drug Monitoring. 17(4). 336–341. 7 indexed citations

17.

Tan, Chay‐Hoon, et al.. (1993). Clinical Evaluation and Serum Concentration of Zuclopenthixol Acetate in Psychotic Asian Patients. Therapeutic Drug Monitoring. 15(2). 108–112. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact